Financial Analysis: Tenon Medical (NASDAQ:TNON) versus Calmare Therapeutics (OTCMKTS:CTTC)

Tenon Medical (NASDAQ:TNON) and Calmare Therapeutics (OTCMKTS:CTTC) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings.

Valuation and Earnings

This table compares Tenon Medical and Calmare Therapeutics”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$2.93 million	2.10	-$15.58 million	($27.23)	-0.07
Calmare Therapeutics	N/A	N/A	N/A	N/A	N/A

Calmare Therapeutics has lower revenue, but higher earnings than Tenon Medical.

Analyst Recommendations

This is a summary of recent ratings for Tenon Medical and Calmare Therapeutics, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	0	0	2	0	3.00
Calmare Therapeutics	0	0	0	0	0.00

Tenon Medical presently has a consensus target price of $5.50, suggesting a potential upside of 180.61%. Given Tenon Medical’s stronger consensus rating and higher possible upside, analysts plainly believe Tenon Medical is more favorable than Calmare Therapeutics.

Insider & Institutional Ownership

22.7% of Tenon Medical shares are held by institutional investors. 4.7% of Tenon Medical shares are held by company insiders. Comparatively, 17.5% of Calmare Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Profitability

This table compares Tenon Medical and Calmare Therapeutics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-413.88%	-1,785.88%	-164.26%
Calmare Therapeutics	N/A	N/A	N/A

Summary

Tenon Medical beats Calmare Therapeutics on 5 of the 9 factors compared between the two stocks.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Calmare Therapeutics

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.